MEDIUM confidence: 100% data completeness, but the composite (41) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$5.6M over 180 days (0 open-market buys, 16 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Avg target $58 (last qtr, 3 analysts) → $58 (last mo, 3) (+0.0%).
Buy-rated share 55% → 64% over ~3 months (+9pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $0.78 | $0.76 | -2.9% |
| Jul 2026 | $0.47 | $0.70 | +48.9% |
| Apr 2026 | $0.23 | $0.33 | +43.5% |
| Feb 2026 | $0.43 | $0.69 | +60.5% |
| Oct 2025 | $0.42 | $0.51 | +21.4% |
| Jul 2025 | $0.16 | $0.22 | +37.5% |
| Apr 2025 | $0.09 | $0.09 | +0.0% |
| Feb 2025 | $0.37 | $0.43 | +16.2% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.1B— | $7.1B+15.5% | $6.5B-8.3% | $6.3B-2.9% | $6.7B+6.2% |
| EPS (dil.) | $2.62— | $3.11+18.7% | $1.46-53.1% | $1.43-2.1% | $1.50+4.9% |
| Free Cash Flow | $342M— | $190M-44.2% | $521M+173.3% | $345M-33.7% | $191M-44.7% |
| Gross Margin | 20.0% | 18.8%-1.2pp | 14.5%-4.3pp | 14.8%+0.3pp | 14.0%-0.8pp |
| Operating Margin | 12.4% | 12.7%+0.2pp | 7.2%-5.4pp | 6.9%-0.3pp | 7.0%+0.0pp |
| Net Margin | 10.5% | 10.8%+0.3pp | 5.5%-5.3pp | 5.6%+0.1pp | 5.6%-0.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 11.5%/yr (revenue basis).
Base free cash flow $352M (avg FY2023–FY2025; latest year $191M) · equity value $9.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 41 for Amkor Technology indicates a neutral outlook, with the stock's value proposition being a relative strength, scoring 58 due to its P/E of 15.5 and P/B of 2.0. However, growth and momentum scores are lower, at 40 and 36 respectively, driven by a decline in free cash flow growth and a recent 24% drop in stock price over the past three months. The long-term and short-term scores diverge slightly, with the long-term score being 6 points higher, suggesting some potential for rebound from current levels. Overall, the stock exhibits strong value characteristics but weak momentum.